目录
- Healthy axis: Towards an integrated view of the gut-brain health
- Hepatocellular carcinoma and metabolic syndrome: The times are changing and so should we
- Improving cirrhosis care: The potential for telemedicine and mobile health technologies
- Lumen-apposing metal stents for malignant biliary obstruction: Is this the ultimate horizon of our experience?
- Pharmacogenetics of the systemic treatment in advanced hepatocellular carcinoma
- Consensus on management of hepatitis C virus infection in resource-limited Ukraine and Commonwealth of Independent States regions
- Immunotherapy in colorectal cancer: Available clinical evidence,challenges and novel approaches
- Hepatocellular carcinoma in the post-hepatitis C virus era: Should we change the paradigm?
- Honokiol-enhanced cytotoxic T lymphocyte activity against cholangiocarcinoma cells mediated by dendritic cells pulsed with damage-associated molecular patterns
- Berberine prevents stress-induced gut inflammation and visceral hypersensitivity and reduces intestinal motility in rats
- LncRNA MEG3 acts a biomarker and regulates cell functions by targeting ADAR1 in colorectal cancer
- Liquid biopsy for non-invasive assessment of liver injury in hepatitis B patients
- Additional laparoscopic gastrectomy after noncurative endoscopic submucosal dissection for early gastric cancer: A single-center experience
- Management of skin toxicities during panitumumab treatment in metastatic colorectal cancer
- Post-endoscopic retrograde cholangiopancreatography pancreatitis:A systematic review for prevention and treatment